| Dr Dalia E Perez-salinas, DDS | |
|
1310 Tara Hills Dr, Suite G, Pinde, CA 94564 | |
| (510) 243-0213 | |
| (510) 243-0217 |
| Full Name | Dr Dalia E Perez-salinas |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 1310 Tara Hills Dr, Pinde, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851399356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 38580 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dalia E Perez-salinas, DDS 1310 Tara Hills Dr, Suite G, Pinde, CA 94564 Ph: (510) 243-0213 | Dr Dalia E Perez-salinas, DDS 1310 Tara Hills Dr, Suite G, Pinde, CA 94564 Ph: (510) 243-0213 |
News Archive
A unique study by scientists at the National Oceanography Centre will provide valuable new insights into the concentrations of microplastics in the open ocean from surface to the sea bed.
Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced today that it has received notice from the U.S. Food and Drug Administration (FDA) that the FDA's Office of Orphan Products Development has granted orphan drug designation to prGCD, the Company's proprietary plant cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.
Areas of the brain responsible for pain processing and cognitive performance changed in fibromyalgia patients who exercised following a medication holiday, say researchers from Georgetown University Medical Center. They say the changes indicate brain functioning is more streamlined after an exercise intervention because less of the brain-s resources is devoted to processing bothersome fibromyalgia perceptions such as pain.
Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Health and Human Service (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved the distribution of the H1NI vaccine to Wall Street firms at a time when the vaccine is unavailable to most Americans.
EndoGastric Solutions (EGS) today announced that new U.S. clinical results for their third generation Transoral Incisionless Fundoplication (TIF2) procedure were presented during the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting April 14-17, in Washington, DC.
› Verified 1 days ago